title: Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders.
authors.forename: Vincenza
authors.initials: V
authors.lastname: Santoro
authors.forename: Concetta
authors.initials: C
authors.lastname: D'Arrigo
authors.forename: Edoardo
authors.initials: E
authors.lastname: Spina
authors.forename: Umberto
authors.initials: U
authors.lastname: Micò
authors.forename: Maria R
authors.initials: MR
authors.lastname: Muscatello
authors.forename: Rocco
authors.initials: R
authors.lastname: Zoccali
mesh_terms: D000328:Adult; D001569:Benzodiazepines / Q000008:administration & dosage / Q000097:blood*; D003024:Clozapine / Q000008:administration & dosage / Q000097:blood*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D000068736:Duloxetine Hydrochloride; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000097:blood* / Q000188:drug therapy; D018967:Risperidone / Q000008:administration & dosage / Q000097:blood*; D013876:Thiophenes / Q000008:administration & dosage / Q000097:blood*; D055815:Young Adult
chemical_list: D013876:Thiophenes; D001569:Benzodiazepines; D000068736:Duloxetine Hydrochloride; D003024:Clozapine; D018967:Risperidone; D000077152:Olanzapine